Feasibility and efficacy of the addition of heart rate variability biofeedback to a remote digital health intervention for depression Marcos Economides a*, Paul Lehrer b, Kristian Ranta a, Albert Nazander a, Outi Hilgert a, Anu Raevuori a,c,d, Richard Gevirtz e, Inna Khazan f, Valerie L. Forman-Hoffman a a Meru Health Inc, Palo Alto, CA, United States b Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, United States c Department of Adolescent Psychiatry, Helsinki University Central Hospital, Helsinki, Finland d Clinicum, Department of Public Health, University of Helsinki, Helsinki, Finland e Department of Clinical Psychology, California School of Professional Psychology, Alliant University, San Diego, United States f Harvard Medical School, Boston Center for Health Psychology and Biofeedback, United States * corresponding author:
[email protected] 1 Abstract A continual rise in the prevalence of depression underscores the need for effective, long-lasting interventions that can be widely accessed. To address this, we created a comprehensive, smartphone-based, 8-week digital intervention comprising several evidence-based practices for adults with depression. Recently, there has been substantial support for heart rate variability biofeedback (HRV-B) as a primary or adjunct treatment for several mental health disorders, including depression. The objectives of this study were to determine if the addition of HRV-B to our original intervention was feasible and whether patients in the HRV-B (“enhanced”) intervention were more likely